664 results match your criteria: "Pediatrics Reactive Airway Disease"
Antioxidants (Basel)
October 2024
Pediatrics, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
BMC Pulm Med
November 2024
Division of Neonatology, Department of Pediatrics, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
Background: Prolonged exposure to hyperoxia can lead to hyperoxic acute lung injury (HALI) in preterm neonates. Vitamin D (VitD) stimulates lung maturation and acts as an anti-inflammatory agent. Our objective was to determine if VitD provides a dose-dependent protective effect against HALI by reducing inflammatory cytokine expression and improving alveolarization and lung function in neonatal mice.
View Article and Find Full Text PDFFront Microbiol
October 2024
Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Background: Airway mucus hypersecretion (AMH) can occur in children with acute respiratory diseases, but its underlying mechanisms and relationship with the lower respiratory tract microbiota (LRTM) are not yet fully understood. This study investigates the characteristics of LRTM in children with pneumonia (MPP) and its impact on AMH.
Methods: We collected bronchoalveolar lavage fluid and related clinical indicators from 202 children with MPP.
Infect Immun
December 2024
Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Children living with HIV have a higher risk of developing tuberculosis (TB), a disease caused by the bacterium (Mtb). Gamma delta (γδ) T cells in the context of HIV/Mtb coinfection have been understudied in children despite evidence suggesting γδ T cells assist with Mtb control. We investigated whether boosting a specific subset of γδ T cells, phosphoantigen-reactive Vγ9+Vδ2+ cells, could improve TB outcome using a nonhuman primate model of pediatric HIV/Mtb coinfection.
View Article and Find Full Text PDFHealth Qual Life Outcomes
October 2024
Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Am J Perinatol
September 2024
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina.
Previable premature prelabor rupture of membranes (pPPROM) can lead to significant maternal and neonatal morbidity and mortality. Limited literature exists describing long-term outcomes in neonates surviving pPPROM. Our study describes 2-year survival and outcomes after expectantly managed pPPROM at a single, tertiary, academic center.
View Article and Find Full Text PDFAntioxidants (Basel)
July 2024
Department of Pediatrics, Medical College of Wisconsin, Suite C410, Children Corporate Center, 999N 92nd Street, Milwaukee, WI 53226, USA.
Bronchopulmonary dysplasia (BPD) is a lung complication of premature births. The leading causes of BPD are oxidative stress (OS) from oxygen treatment, infection or inflammation, and mechanical ventilation. OS activates alveolar myeloid cells with subsequent myeloperoxidase (MPO)-mediated OS.
View Article and Find Full Text PDFBMJ Case Rep
August 2024
Division of Medical Toxicology, Ronald O. Perelman Department of Emergency Medicine, New York University Grossman School of Medicine, New York, New York, USA.
A 22-kg female in early childhood with a history of reactive airway disease presented to a paediatric emergency department with acute shortness of breath, tachypnoea and wheezing. Despite treatment with albuterol and corticosteroids, her bronchospasm persisted, prompting the administration of terbutaline. The patient received 220 mcg (10 mcg/kg) terbutaline intravenously, followed immediately by an inadvertent supratherapeutic intravenous dose of 10 000 mcg (454.
View Article and Find Full Text PDFCureus
July 2024
Pediatric Intensive Care Unit, Centro Materno Infantil do Norte, Centro Hospitalar Universitário do Porto, Porto, PRT.
bioRxiv
July 2024
Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Children living with HIV have a higher risk of developing tuberculosis (TB), a disease caused by the bacterium (Mtb). Gamma delta (γδ) T cells in the context of HIV/Mtb coinfection have been understudied in children, despite evidence suggesting γδ T cells assist with Mtb control. We investigated whether boosting a specific subset of γδ T cells, phosphoantigen-reactive Vγ9+Vδ2+ cells, could improve TB outcome using a nonhuman primate model of pediatric HIV/Mtb coinfection.
View Article and Find Full Text PDFJ Patient Exp
July 2024
University of Central Florida College of Medicine, Nemours Children's Health Department of Pediatrics, Orlando, FL, USA.
JCI Insight
July 2024
Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
Int J Pediatr
June 2024
Department of Pediatrics The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Zhonghua Er Ke Za Zhi
July 2024
Department Ⅱ of Respiratory Center, National Clinical Research Center for Respiratory Diseases, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
J Asthma
December 2024
Division of Pediatric Hospital Medicine, Medical College of WI, Children's Wisconsin, Milwaukee, WI, USA.
Objectives: Dexamethasone has become the standard of care for pediatric patients with status asthmaticus in the emergency department (ED) setting. Inpatient providers often must decide between continuing the second dose of dexamethasone or transitioning to prednisone. The effectiveness of receiving dexamethasone followed by prednisone (combination therapy) compared to only prednisone or dexamethasone remains unclear.
View Article and Find Full Text PDFJ Clin Med
May 2024
Department of Woman, Child and of General and Specialized Surgery, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
Nat Commun
June 2024
Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Iran J Allergy Asthma Immunol
April 2024
Henan University of Chinese Medicine, Zhengzhou, China.
Iran J Allergy Asthma Immunol
April 2024
Department of Pediatrics, School of Medicine Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran.
Antioxidants (Basel)
April 2024
Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
J Paediatr Child Health
June 2024
Paediatric Research in Emergency Departments International Collaborative (PREDICT), Melbourne, Victoria, Australia.
Iran J Allergy Asthma Immunol
December 2023
Department of Respiratory Medicine, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian Province, China.
Antioxidants (Basel)
February 2024
Valencia University Clinical Hospital Research Foundation, Instituto de Investigación Sanitaria INCLIVA, Avda. Menéndez y Pelayo, 4, 46010 Valencia, Spain.
Rhinology
June 2024
KU Leuven, Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, Leuven, Belgium; University Hospitals Leuven, Department of Otorhinolaryngology, Head and Neck surgery, Leuven, Belgium;KU Leuven, Department of Neurosciences, Experimental Otorhinolaryngology, Leuven, Belgium.